|
|
Volumn 21, Issue 23, 2003, Pages 4268-4269
|
|
Epidermal growth factor receptor overexpression: The importance of context
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
MORPHINE;
PACLITAXEL;
TRASTUZUMAB;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
EDITORIAL;
GENE AMPLIFICATION;
GENE OVEREXPRESSION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LUNG NON SMALL CELL CANCER;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT RESPONSE;
CHROMOSOME 7;
GENE DOSAGE;
GENE REARRANGEMENT;
GENETICS;
LUNG TUMOR;
METABOLISM;
NOTE;
PROGNOSIS;
PROTO ONCOGENE;
UPREGULATION;
CARCINOMA, NON-SMALL-CELL LUNG;
CHROMOSOMES, HUMAN, PAIR 7;
GENE AMPLIFICATION;
GENE DOSAGE;
GENE REARRANGEMENT;
GENES, ERBB-1;
HUMANS;
LUNG NEOPLASMS;
PROGNOSIS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
UP-REGULATION;
|
|
EID: 0642276783
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2003.05.988 Document Type: Editorial |
|
Times cited : (8)
|
|
References (6)
|
